期刊文献+

阴道镜和高危型HPV-DNA检测在宫颈不典型病变筛查中的应用 被引量:13

Application of HPV-DNA Detection and Colposcopy in Screening of Cervical Atypical Lesions
原文传递
导出
摘要 目的评估阴道镜和高危型HPV-DNA检测及两种方法联合在宫颈病变筛查中的应用价值。方法采用HPV-DNA检测、阴道镜检查结合Reid评分系统及镜下多点活检对196例超薄液基细胞学检查(TCT)阴性(炎症反应性细胞改变)的接触性阴道出血症状患者进行分流诊断。结果 196例患者中,阴道镜检查阳性率(Reid评分≥1分)达31.6%(62/196);高危型HPV-DNA阳性率达33.2%(65/196);宫颈活检诊断为宫颈病变率31.1%(61/196),且随着活检病变程度加重,阴道镜Reid评分(rp=0.713,P<0.001)和高危型HPV-DNA检测阳性率(rp=0.538,P<0.001)逐渐上升。以宫颈组织病理学检查结果为确诊标准,阴道镜、高危型HPV-DNA检测及两方法联合诊断宫颈病变的灵敏度、特异度、阳性预测值及阴性预测值分别为72.1%、88.1%、73.3%、87.5%;68.9%、83.0%、64.6%、85.5%;90.2%、92.6%、84.6%、95.4%。结论接触性阴道出血患者即使TCT阴性仍然存在一定的宫颈癌前病变及癌变风险,联合应用阴道镜和高危型HPV-DNA检测有助于建立良好的分流诊断,降低漏诊率和过度诊断率。 Objective To investigate the diagnosis value and clinical significance high risk HPV-DNA detection and colpos- copy in screening of cervical atypical lesions. Methods HPV-DNA detection, colposeopy combined with Reid scoring system and endoscopic multiple biopsy were performed in 196 participants with negative result( inflammatory response of ceils) of ThinPrep liquid based cytology test and symptoms of vaginal contact bleeding. Results In 196 cases,by cytology,the positive rate was 31.6% (62/196) ;By high-risk HPV-DNA detection, the positive rate was 33.2% (65/196). The positive rate of endoscopic mul- tiple biopsy detection was 61/196 ( 31.1% ). with the severity of cervical biopsy lesions, the degree of colposcopy Reid score ( rp = 0.713, P 〈 0. 001 ) and high-risk HPV-DNA positive rate ( rp = 0.538, P 〈 0. 001 ) gradually increased. Taking biopsy pathology results as standard, the sensitivity, specificity, positive predictive values and negative predictive values of cytology were 72.1%, 88.1% ,73.3% and 87.5% ,respectively;and of high risk HPV-DNA detection were 68.9% ,83.0% ,64.6% and 85.5% ,re- spectively;Additionally,these assessment indicators were 90.2% ,92.6% ,84.6% and 95.4% by combined of the two above- mentioned screening methods. Conclusion There are still some cervical precancerous lesions and cancer risk in patient with symptoms of vaginal contact bleeding Even if the ThinPrep cytologic test was negative. Combined colposcopy and high-risk HPV- DNA testing can help establish a good diversion diagnosis, and reduce the rate of misdiagnosis and over-diagnosis.
出处 《中华全科医学》 2013年第6期854-855,975,共3页 Chinese Journal of General Practice
关键词 宫颈疾病 阴道镜 筛查 Cervical disease Colposcopy Screening
  • 相关文献

参考文献10

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clin,2011,61 (2) :69-90. 被引量:1
  • 2顾彩珑,王玉萍,党秋红,张发顺.薄层液基细胞学检测诊断宫颈癌及癌前病变的价值[J].中华实用诊断与治疗杂志,2012,26(9):890-892. 被引量:18
  • 3de Bekker-Grob EW, de Kok IM, Bulten J, et al. Liquid-based cervical cytology using ThinPrep technology:weighing the pros and cons in a cost-effectiveness analysis [ J ]. Cancer Causes Control, 2012,23 ( 8 ) : 1323-1331. 被引量:1
  • 4Boonlikit S. Correlation between Reid' s colposcopic index and histo- logic results from colposcopically directed biopsy in differentiating high-grade from low-grade squamous intraepithelial lesion at Rajavithi Hospital [ J ]. J Med Assoc Thai,2011,94 ( Suppl 2 ) : $59 -$65. 被引量:1
  • 5刘树范.浅析巴氏五级分类法与TBS描述性诊断报告方式[J].中国实用妇科与产科杂志,2003,19(3):135-137. 被引量:167
  • 6Rogers L, Siu SS, Luesley D,et al. Radiotherapy and chemoradiation after surgery for early cervical cancer [ J ]. Cochrane Database Syst Rev,2012,5 : CD007583. 被引量:1
  • 7Machado FA, Janssens JP, Michelin MA, et al. Immune response and immune- therapy in intraepithelial and invasive lesions of the uterine cervix[ J]. Clin Exp Obstet Gyneeol,2012,39( 1 ) :27-31. 被引量:1
  • 8邵敏芳,钱志红.阴道镜联合HPV-DNA检测对宫颈不典型鳞状细胞的诊断价值[J].苏州大学学报(医学版),2011,31(2):336-337. 被引量:5
  • 9Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, A- merican Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer[ J]. CA Cancer J Clin,2012,62 (3) :147-172. 被引量:1
  • 10New recommendations from the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology. Testing for cervical cancer [ J ]. CA Cancer J Clin,2012,62 (3) :211-212. 被引量:1

二级参考文献17

共引文献186

同被引文献81

引证文献13

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部